糖尿病患者-话题@MedSci

#糖尿病患者#

1747篇内容 | 8037人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1475342, encodeId=ffcc14e534207, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Front Immunol：维生素D补充剂调节2型糖尿病患者血小板介导的炎症, objectType=article, longId=736726, objectId=8012e3672677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8012e3672677, replyNumber=0, likeNumber=122, createdTime=2022-08-25, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8012e3672677, moduleTitle=Front Immunol：维生素D补充剂调节2型糖尿病患者血小板介导的炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8012e3672677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475340, encodeId=a04714e5340f5, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Acta Diabetol：降糖药与初级保健的2型糖尿病患者卒中和短暂性脑缺血发作的相关性, objectType=article, longId=736723, objectId=97d7e3672315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97d7e3672315, replyNumber=0, likeNumber=86, createdTime=2022-08-25, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97d7e3672315, moduleTitle=Acta Diabetol：降糖药与初级保健的2型糖尿病患者卒中和短暂性脑缺血发作的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97d7e3672315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475339, encodeId=c9a114e53390b, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Front Pharmacol：2型糖尿病患者使用DPP-4i、GLP-1 RAs和SGLT-2i的骨折风险, objectType=article, longId=736722, objectId=3a36e36722e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a36e36722e3, replyNumber=0, likeNumber=74, createdTime=2022-08-25, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a36e36722e3, moduleTitle=Front Pharmacol：2型糖尿病患者使用DPP-4i、GLP-1 RAs和SGLT-2i的骨折风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a36e36722e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475338, encodeId=f2f914e5338de, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究, objectType=article, longId=736517, objectId=930ce36517e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=930ce36517e1, replyNumber=0, likeNumber=92, createdTime=2022-08-23, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=930ce36517e1, moduleTitle=Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=930ce36517e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475337, encodeId=404914e53377c, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Front Med：磺脲类药物或双胍类药物与降低糖尿病患者类风湿性关节炎风险的相关性, objectType=article, longId=736514, objectId=b8d0e36514fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8d0e36514fb, replyNumber=0, likeNumber=76, createdTime=2022-08-23, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8d0e36514fb, moduleTitle=Front Med：磺脲类药物或双胍类药物与降低糖尿病患者类风湿性关节炎风险的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8d0e36514fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475335, encodeId=66de14e5335d6, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=口服降糖药可降低糖尿病患者类风湿关节炎的发病风险！磺脲类vs二甲双胍，二者谁更优？, objectType=article, longId=736147, objectId=bb9ae361478e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb9ae361478e, replyNumber=0, likeNumber=112, createdTime=2022-08-19, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb9ae361478e, moduleTitle=口服降糖药可降低糖尿病患者类风湿关节炎的发病风险！磺脲类vs二甲双胍，二者谁更优？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb9ae361478e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475336, encodeId=accb14e5336d6, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=BMC Med：用SGLT2抑制剂治疗的慢性肾病和2型糖尿病患者的心肾并发症和治疗失败的预测因素, objectType=article, longId=736106, objectId=5cc6e3610606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cc6e3610606, replyNumber=0, likeNumber=83, createdTime=2022-08-19, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cc6e3610606, moduleTitle=BMC Med：用SGLT2抑制剂治疗的慢性肾病和2型糖尿病患者的心肾并发症和治疗失败的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cc6e3610606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475334, encodeId=a3ed14e533488, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Front Biosci：局部使用天然抗氧化剂α-硫辛酸对具有干眼症状的糖尿病患者的眼表的影响, objectType=article, longId=735930, objectId=0717e35930c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0717e35930c2, replyNumber=0, likeNumber=81, createdTime=2022-08-17, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0717e35930c2, moduleTitle=Front Biosci：局部使用天然抗氧化剂α-硫辛酸对具有干眼症状的糖尿病患者的眼表的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0717e35930c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475328, encodeId=789614e532887, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=磺脲类药物可增加2型糖尿病患者的癌症风险？最新研究答案是“No”！, objectType=article, longId=735644, objectId=a962e3564404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a962e3564404, replyNumber=0, likeNumber=93, createdTime=2022-08-13, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a962e3564404, moduleTitle=磺脲类药物可增加2型糖尿病患者的癌症风险？最新研究答案是“No”！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a962e3564404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475333, encodeId=756214e533303, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：使用SGLT2i、GLP1RA和DPP-4抑制剂治疗的2型糖尿病患者发生房颤的风险, objectType=article, longId=735642, objectId=ed39e3564211, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed39e3564211, replyNumber=0, likeNumber=95, createdTime=2022-08-13, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed39e3564211, moduleTitle=Cardiovasc Diabetol：使用SGLT2i、GLP1RA和DPP-4抑制剂治疗的2型糖尿病患者发生房颤的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed39e3564211)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475327, encodeId=7c5f14e532734, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Front Endocrinol：磺脲类降糖药与2型糖尿病患者的患癌风险, objectType=article, longId=735608, objectId=e93ee35608c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e93ee35608c6, replyNumber=0, likeNumber=84, createdTime=2022-08-12, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e93ee35608c6, moduleTitle=Front Endocrinol：磺脲类降糖药与2型糖尿病患者的患癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e93ee35608c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475331, encodeId=fc0614e5331b9, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Adv Ther：肥胖和长期1型糖尿病患者周围神经病变的患病率和特征比较, objectType=article, longId=735309, objectId=d5b5e35309d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5b5e35309d7, replyNumber=0, likeNumber=83, createdTime=2022-08-10, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5b5e35309d7, moduleTitle=Adv Ther：肥胖和长期1型糖尿病患者周围神经病变的患病率和特征比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5b5e35309d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475330, encodeId=b47614e5330a4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=PLoS One：不同降糖药物对2型糖尿病患者动脉粥样硬化性心血管疾病风险评分的影响, objectType=article, longId=735307, objectId=2702e353073e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2702e353073e, replyNumber=0, likeNumber=87, createdTime=2022-08-10, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2702e353073e, moduleTitle=PLoS One：不同降糖药物对2型糖尿病患者动脉粥样硬化性心血管疾病风险评分的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2702e353073e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475329, encodeId=543414e53293f, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetologia：1型糖尿病和非1型糖尿病患者反调节激素的血糖阈值和对低血糖的症状反应, objectType=article, longId=735306, objectId=a7f8e3530696, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7f8e3530696, replyNumber=0, likeNumber=89, createdTime=2022-08-10, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7f8e3530696, moduleTitle=Diabetologia：1型糖尿病和非1型糖尿病患者反调节激素的血糖阈值和对低血糖的症状反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7f8e3530696)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475326, encodeId=479514e5326e8, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：糖化ACE2可降低糖尿病患者心脏中RAS系统抑制的抗重构作用, objectType=article, longId=735303, objectId=ae19e3530333, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae19e3530333, replyNumber=0, likeNumber=111, createdTime=2022-08-10, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae19e3530333, moduleTitle=Cardiovasc Diabetol：糖化ACE2可降低糖尿病患者心脏中RAS系统抑制的抗重构作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae19e3530333)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475332, encodeId=33a014e533295, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=糖尿病患者出现手麻就是糖尿病神经病变？症结其实出在患者的睡姿上, objectType=article, longId=734469, objectId=3c49e34469a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c49e34469a5, replyNumber=0, likeNumber=197, createdTime=2022-08-06, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c49e34469a5, moduleTitle=糖尿病患者出现手麻就是糖尿病神经病变？症结其实出在患者的睡姿上, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c49e34469a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475323, encodeId=7d4d14e532369, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=吃辅酶Q10是交智商税吗？LANCET子刊：对于糖尿病患者还真不是！每天服用100-200mg最佳！, objectType=article, longId=734410, objectId=07abe3441001, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07abe3441001, replyNumber=0, likeNumber=107, createdTime=2022-08-06, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07abe3441001, moduleTitle=吃辅酶Q10是交智商税吗？LANCET子刊：对于糖尿病患者还真不是！每天服用100-200mg最佳！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07abe3441001)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475324, encodeId=47fc14e53243a, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=BMC Med：合并或不合并糖尿病患者的收缩压控制在目标范围内的临床益处, objectType=article, longId=734245, objectId=354ee342457b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=354ee342457b, replyNumber=0, likeNumber=81, createdTime=2022-08-04, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=354ee342457b, moduleTitle=BMC Med：合并或不合并糖尿病患者的收缩压控制在目标范围内的临床益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=354ee342457b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475322, encodeId=873a14e5322a8, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=JAMA子刊：这类糖尿病患者癌症风险可升高5倍！都是胰岛素治疗惹的祸？, objectType=article, longId=734198, objectId=d323e3419822, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d323e3419822, replyNumber=0, likeNumber=107, createdTime=2022-08-04, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d323e3419822, moduleTitle=JAMA子刊：这类糖尿病患者癌症风险可升高5倍！都是胰岛素治疗惹的祸？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d323e3419822)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475325, encodeId=d2f414e5325d2, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Bioact Mater：壳聚糖@葛根素水凝胶促进糖尿病患者的伤口愈合, objectType=article, longId=734031, objectId=4837e3403125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4837e3403125, replyNumber=0, likeNumber=104, createdTime=2022-08-01, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4837e3403125, moduleTitle=Bioact Mater：壳聚糖@葛根素水凝胶促进糖尿病患者的伤口愈合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4837e3403125)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

糖尿病患者

2020-05-29

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Front Immunol：维生素D补充剂调节2型糖尿病患者血小板介导的炎症

2022-08-25

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Acta Diabetol：降糖药与初级保健的2型糖尿病患者卒中和短暂性脑缺血发作的相关性

2022-08-25

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Front Pharmacol：2型糖尿病患者使用DPP-4i、GLP-1 RAs和SGLT-2i的骨折风险

2022-08-25

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究

2022-08-23

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Front Med：磺脲类药物或双胍类药物与降低糖尿病患者类风湿性关节炎风险的相关性

2022-08-23

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

口服降糖药可降低糖尿病患者类风湿关节炎的发病风险！磺脲类vs二甲双胍，二者谁更优？

2022-08-19

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

BMC Med：用SGLT2抑制剂治疗的慢性肾病和2型糖尿病患者的心肾并发症和治疗失败的预测因素

2022-08-19

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Front Biosci：局部使用天然抗氧化剂α-硫辛酸对具有干眼症状的糖尿病患者的眼表的影响

2022-08-17

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

磺脲类药物可增加2型糖尿病患者的癌症风险？最新研究答案是“No”！

2022-08-13

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol：使用SGLT2i、GLP1RA和DPP-4抑制剂治疗的2型糖尿病患者发生房颤的风险

2022-08-13

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Front Endocrinol：磺脲类降糖药与2型糖尿病患者的患癌风险

2022-08-12

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Adv Ther：肥胖和长期1型糖尿病患者周围神经病变的患病率和特征比较

2022-08-10

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

PLoS One：不同降糖药物对2型糖尿病患者动脉粥样硬化性心血管疾病风险评分的影响

2022-08-10

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetologia：1型糖尿病和非1型糖尿病患者反调节激素的血糖阈值和对低血糖的症状反应

2022-08-10

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol：糖化ACE2可降低糖尿病患者心脏中RAS系统抑制的抗重构作用

2022-08-10

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

糖尿病患者出现手麻就是糖尿病神经病变？症结其实出在患者的睡姿上

2022-08-06

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

吃辅酶Q10是交智商税吗？LANCET子刊：对于糖尿病患者还真不是！每天服用100-200mg最佳！

2022-08-06

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

BMC Med：合并或不合并糖尿病患者的收缩压控制在目标范围内的临床益处

2022-08-04

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

JAMA子刊：这类糖尿病患者癌症风险可升高5倍！都是胰岛素治疗惹的祸？

2022-08-04

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Bioact Mater：壳聚糖@葛根素水凝胶促进糖尿病患者的伤口愈合

2022-08-01

科室
- - 订阅+
  - 更多科室
工具
服务